Emerging Diagnostic Modalities & Innovation
|2 min read
AI Tool Uses Routine Pathology Slides to Predict Brain Tumor Recurrence Risk
AI models predicted meningioma recurrence risk and tumor subtype from routine pathology slides, potentially expanding access to molecular insights without genetic testing
Available on Demand
Your Model From Our Experience: Cloud First Digital Pathology in a High-Volume Regional Laboratory
Join Dark Daily to Learn How Eastern Ontario Went Digital in the CloudSponsored by
|2 min read
Genetic Study Highlights New Possibilities for Diabetes Prevention and Laboratory Testing
Researchers found certain prediabetic patients may benefit from vitamin D supplementation based on genetic variations, underscoring the growing role of laboratory testing in personalized diabetes prevention strategies
|2 min read
Paper-Based Device Detects Cancer Biomarker miRNA-21 via Smartphone Readout
Paper-based nanozyme device enables rapid detection of cancer biomarker miRNA-21 for potential point-of-care use
Available on Demand
Denial Trends, Appeals Insights & Agentic AI: A New Playbook for Appeal Success
Don’t miss this opportunity to understand the denial and appeals trends reshaping reimbursement—and the operational pressures labs must now navigate.Sponsored by
|3 min read
Ensuring Compliance: How to Get AI Diagnostic Tools Approved for Clinical Practice
A regulatory roadmap for AI diagnostic tool developmentSponsored by
|2 min read
OpenAI’s “ChatGPT for Clinicians” Could Signal Bigger Changes Ahead for Clinical Laboratories
The new healthcare AI platform offers physicians support for documentation, research, and clinical workflows, while raising broader questions for laboratories about oversight, workflow integration, and the growing role of generative AI in healthcare
|2 min read
New Study Could Improve Testing and Treatment for Rare Brain, Spinal Cord, and Eye Cancers
A newly identified biomarker could enable earlier, less invasive diagnosis and improved disease monitoring of some rare and aggressive cancers
|2 min read
The Bayesian Breakthrough: Transparent AI in Clinical Trials
FDA draft guidance on Bayesian methods is driving more transparent, data-driven clinical trial design
|2 min read
Executive War College Organizer Offers Five Predictions Stemming from the Event
Conference producer Ashleigh Harris had a front-row seat to planning calls, content development, and speaker feedback
|2 min read
New Blood Test Detects Testicular Cancers Missed by Standard Markers
Mayo Clinic researchers have developed two new blood tests that use immune system signals to improve detection and classification of testicular germ cell tumors
|3 min read
